| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/11/2012 | CN101485753B Chinese medicine for treating hepatitis B and preparation method thereof |
| 01/11/2012 | CN101396542B Traditional Chinese medicine formulation for treating gastrosis and preparation method thereof |
| 01/11/2012 | CN101390970B Traditional Chinese medicine for treating hepatitis B and preparation method thereof |
| 01/11/2012 | CN101220373B Recombined viral vectors and uses thereof |
| 01/11/2012 | CN101190281B Prune tree extract and preparation method and application thereof |
| 01/11/2012 | CN101045083B Dizziness-clearing soft capsule, its preparing method and detection method |
| 01/10/2012 | US8093417 Lipoxin analogs and methods for the treatment of periodontal disease |
| 01/10/2012 | US8093392 Caspase inhibitors and uses thereof |
| 01/10/2012 | US8093278 Substituted indoles |
| 01/10/2012 | US8093271 Anti-acid pharmaceutical composition in powder form and process for making it |
| 01/10/2012 | US8092793 Treating inflammatory bowel disease with live bacteria |
| 01/10/2012 | US8092608 Administering oligosaccharides |
| 01/10/2012 | CA2528653C Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
| 01/10/2012 | CA2526079C Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
| 01/10/2012 | CA2503719C Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 01/10/2012 | CA2479666C (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 01/10/2012 | CA2464334C Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 01/10/2012 | CA2436665C Nucleic acid derivatives |
| 01/10/2012 | CA2419541C Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 01/10/2012 | CA2382105C Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 01/10/2012 | CA2222563C Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field |
| 01/05/2012 | WO2012003477A2 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors |
| 01/05/2012 | WO2012003290A2 Dental composites comprising nanoparticles of amorphous calcium phosphate |
| 01/05/2012 | WO2012002654A2 Natural food composition for treating constipation in weak-bladder body type person |
| 01/05/2012 | WO2012002653A2 Natural food composition for treating constipation in weak-stomach body type person |
| 01/05/2012 | WO2012002562A1 Modified protein therapeutics |
| 01/05/2012 | WO2012002502A1 Dihydropyrimidinone derivative and pharmaceutical use thereof |
| 01/05/2012 | WO2012000667A1 Axomadol or metabolite thereof for use in the treatment of irritable bowel syndrome |
| 01/05/2012 | WO2012000666A1 Tapentadol for use in the treatment of irritable bowel syndrome |
| 01/05/2012 | WO2012000212A1 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof |
| 01/05/2012 | WO2011135544A3 Methods and compositions for treating hepatitis with anti-cd3 immune molecule therapy |
| 01/05/2012 | WO2011126853A9 Prevention or delay of onset of oral mucositis |
| 01/05/2012 | WO2011112428A3 Arylvinylazacycloalkane compounds for constipation |
| 01/05/2012 | WO2011107970A3 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect. |
| 01/05/2012 | WO2011107870A3 Compounds and compositions and their use in the treatment of diseases related to copper retention |
| 01/05/2012 | WO2011091167A3 Lysophosphatidic acid receptor targeting for scleroderma and other fibrotic diseases |
| 01/05/2012 | WO2011075471A3 Novel npr-b agonists and methods of use for the treatment of c-type natriuretic peptide-mediated disorders |
| 01/05/2012 | US20120004317 Tapentadol for use in the treatment of irritable bowel syndrome |
| 01/05/2012 | US20120004313 Crystalline form vi of agomelatine, preparation method and application thereof |
| 01/05/2012 | US20120004311 Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic b-cell lymphoma/leukemia-2 (bcl-2) |
| 01/05/2012 | US20120004276 Rna antagonist compounds for the inhibition of expression of mitochondrial glycerol-3 phosphate acyltransferase 1 (mtgpat1) |
| 01/05/2012 | US20120004275 Sceletium extract and uses thereof |
| 01/05/2012 | US20120004270 Selective Androgen Receptor Modulators |
| 01/05/2012 | US20120004267 Apoptosis signal-regulating kinase inhibitors |
| 01/05/2012 | US20120004263 Compounds for the treatment of pathologies associated with aging and degenerative disorders |
| 01/05/2012 | US20120004246 Purinyl derivatives and their use as potassium channel modulators |
| 01/05/2012 | US20120004244 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004243 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 01/05/2012 | US20120004233 Tricyclic compounds as antagonists of prostaglandin d2 receptors |
| 01/05/2012 | US20120004228 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004223 Compounds, compositions and methods for reducing lipid levels |
| 01/05/2012 | US20120004220 Selective androgen receptor modulators (sarms) and uses thereof |
| 01/05/2012 | US20120004217 Therapeutic agents useful for treating pain |
| 01/05/2012 | US20120004216 Modulators of atp-binding cassette transporters |
| 01/05/2012 | US20120004215 N-oxides of diazabicyclononyl pyrimidine derivatives and their medical use |
| 01/05/2012 | US20120004214 N-oxides of 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine receptor ligands |
| 01/05/2012 | US20120004211 1,2,4-triazole derivatives as sigma receptor inhibitors |
| 01/05/2012 | US20120004207 Therapeutic uses of derivatives of piperidinyl-and piperidinyl-alkyl carbamates |
| 01/05/2012 | US20120004205 Il-13 induced gene signature for eosinophilic esophagitis |
| 01/05/2012 | US20120004202 Medicaments for the treatment or prevention of fibrotic diseases |
| 01/05/2012 | US20120004201 Phosphodiestarase inhibitors |
| 01/05/2012 | US20120004192 Use of lactulose in the treatment of autism |
| 01/05/2012 | US20120004184 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2 |
| 01/05/2012 | US20120004170 Formulation Comprising Bioactive Agents And Method Of Using Same |
| 01/05/2012 | US20120004168 Exendins and exendin agonist analogs to regulate gastrointestinal motility |
| 01/05/2012 | US20120004160 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation |
| 01/05/2012 | US20120003342 Pharmaceutical composition for treating or releiving inflammatory bowel disease |
| 01/05/2012 | US20120003337 Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| 01/05/2012 | US20120003328 Modified sodium-montmorillonite, preparation method and uses thereof |
| 01/05/2012 | US20120003317 Stable probiotic granulate, and method for preparing same |
| 01/05/2012 | US20120003314 Delayed-release oral pharmaceutical composition for treatment of colonic disorders |
| 01/05/2012 | US20120003311 Method for controlled release of an acid-unstable physiologically active substance |
| 01/05/2012 | US20120003252 Isoforms of human somatostatin receptor type 5 produced by alternative processing and oligo-nucleotide pairs for detection thereof by pcr |
| 01/05/2012 | US20120003242 Modulating pdx-1 with pcif1, methods and uses thereof |
| 01/05/2012 | US20120003228 Methods for predicting autoimmune disease risk |
| 01/05/2012 | US20120003205 Pharmaceutical composition containing arazyme for the prevention of liver dysfunction |
| 01/05/2012 | US20120003187 Biological medium for preserving a preparation of insulin-secreting cells |
| 01/05/2012 | US20120003158 Biomarkers for Inflammatory Bowel Disease and Methods Using the Same |
| 01/05/2012 | US20120003153 Novel indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use |
| 01/05/2012 | US20120000998 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 01/05/2012 | DE102010025864A1 Use of lucidone for treating hepatitis, preferably alcoholic hepatitis |
| 01/05/2012 | CA2807303A1 Inhibition of inflammation by simultaneous blockade of multiple prostanoid receptors |
| 01/05/2012 | CA2803660A1 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof |
| 01/05/2012 | CA2795923A1 Tapentadol for use in the treatment of irritable bowel syndrome |
| 01/04/2012 | EP2402330A1 Pyrazolone-derivatives as PDE4 inhibitors |
| 01/04/2012 | EP2402326A1 Crystals of hydrochloride salts of a Phenylalanine Derivative, Production Method Thereof and Use Thereof as alpha4 integrin Inhibitors |
| 01/04/2012 | EP2402310A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2402309A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2402021A1 Pharmaceutical composition for treating or releiving inflammatory bowel disease |
| 01/04/2012 | EP2402020A1 Pharmaceutical composition comprising extracts of Bupleurum with immunomodulating function |
| 01/04/2012 | EP2402018A1 Magnesium oxide fine granules |
| 01/04/2012 | EP2401268A1 Oxyindole derivatives with motilin receptor agonistic activity |
| 01/04/2012 | EP2400966A1 Combination of a nucleoside polymerase inhibitor with a macrocyclic protease inhibitor and use thereof in the treatment of hepatitis c, liver fibrosis and impaired liver function |
| 01/04/2012 | EP2400962A1 Drug combinations containing pde4 inhibitors and nsaids |
| 01/04/2012 | EP2400961A1 Drug combinations containing pde4 inhibitors and nsaids |
| 01/04/2012 | EP1830829B1 Sphingolipids in treatment and prevention of hepatic steatosis |
| 01/04/2012 | CN1944460B Alr polypeptide and application thereof |
| 01/04/2012 | CN1558765B Enantiomerically pure opioid diarylmethylpiperzine and methods of using same |
| 01/04/2012 | CN102307992A Method for treating or preventing a pancreatic dysfunction |
| 01/04/2012 | CN102307896A Fibronectin type III domain based scaffold compositions, methods and uses |